Royalty Pharma plc RPRX
$54.25
▼ -0.76% 24H
About
Royalty Pharma plc is the world's largest buyer of biopharmaceutical royalties and a leading funder of innovation in the life sciences sector. The company acquires royalties entitling it to payments based on net sales of approved therapies and development-stage product candidates, partnering with innovators from academ…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees100
TickerRPRX
Statistics
Market Cap$24.07B
Revenue (TTM)$2.38B
Net Income$770.9M
Net Margin32.4%
EPS$1.78
P/E28.69
P/S12.86
P/B3.51
EV/EBITDA22.08
ROE13.8%
Dividend Yield1.71%
Price$54.25
Data: Twelve Data · Revenue = mcap / P/S